Share

November 10, 2020; 95 (19) Humanities in Neurology

A neurologist in the COVID unit

Reflections on a redeployment

Stephen C. Krieger
First published September 14, 2020, DOI: https://doi.org/10.1212/WNL.0000000000010850
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 95 no. 19 877-880
DOI: 
https://doi.org/10.1212/WNL.0000000000010850
PubMed: 
32928972
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published September 14, 2020.

Article Versions

Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Stephen C. Krieger, MD
  1. Stephen C. Krieger, MD
    2. Scientific Advisory Boards:

    1. (1) Teva, Scientific Advisory Board (2) MedDay, Adjudication Committee (3) TG Therapeutics, Adjudication Committee

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Biogen - honoraria for non-promotional lectures (2) Novartis - honoraria for non-promotional lectures (3) Genzyme - honoraria for non-promotional journal club (4) EMD Serono - honoraria for non-promotional journal club (5) Genentech - honoraria for non-promotional lectures (6) National MS Society - lecture

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Biogen, (2) EMD Serono, (3) Genzyme, (4) Genentech, (5) Novartis, (6) Mallinckrodt, (7) Teva

    Speakers' Bureaus:

    1. (1) Biogen, non-promotional speaker, (2) Novartis, non- promotional speaker (3) EMD Serono, non-promotional speaker, (4) Genentech, non-promotional speaker

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Biogen, (2) Novartis

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Correspondence
    Dr. Krieger stephen.krieger{at}mssm.edu
View Full Text

Article usage

Article usage: to

AbstractFullPdfSource

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me